
Burning Rock Biotech Limited BNR
€ 15.34
11.3%
Geschäftsbericht 2021
hinzugefügt 23.12.2023
Burning Rock Biotech Limited ROE 2011-2026 | BNR
ROE Jährlich Burning Rock Biotech Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -43.17 | -16.82 | 18.97 | 29.41 | - | - | - | - | - | - | - |
Alle Zahlen in CNY-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 29.41 | -43.17 | -2.9 |
ROE anderer Aktien in der Diagnostik & Forschung
| Name | ROE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
22.45 | $ 117.5 | 2.1 % | $ 35.7 B | ||
|
Check-Cap Ltd.
CHEK
|
1734.41 | - | - | $ 9.42 M | ||
|
Aspira Women's Health
AWH
|
184.36 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | ||
|
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
-7.05 | $ 16.83 | 4.86 % | $ 897 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M | ||
|
Exact Sciences Corporation
EXAS
|
-8.66 | - | - | $ 19.8 B | ||
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
-227.33 | $ 1.45 | 5.84 % | $ 1.93 M | ||
|
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M | ||
|
Castle Biosciences
CSTL
|
4.0 | $ 23.53 | 1.73 % | $ 654 M | ||
|
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
-4.56 | $ 178.34 | 1.53 % | $ 8.84 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | ||
|
Interpace Biosciences
IDXG
|
109.89 | $ 2.2 | -4.35 % | $ 9.73 M | ||
|
Danaher Corporation
DHR
|
6.88 | $ 195.87 | 3.3 % | $ 140 B | ||
|
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
-51.54 | $ 126.96 | 4.99 % | $ 20.2 B | ||
|
Fulgent Genetics
FLGT
|
-3.77 | $ 15.3 | 6.03 % | $ 463 M | ||
|
Guardant Health
GH
|
419.18 | $ 82.21 | 4.59 % | $ 10.3 B | ||
|
QIAGEN N.V.
QGEN
|
11.25 | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
-72.07 | $ 2.85 | 5.95 % | $ 92.5 K | ||
|
Medpace Holdings
MEDP
|
98.27 | $ 501.23 | 1.56 % | $ 14.5 B | ||
|
Biomerica
BMRA
|
-121.14 | $ 2.08 | -2.8 % | $ 4.78 M | ||
|
Koninklijke Philips N.V.
PHG
|
9.97 | $ 28.55 | 0.87 % | $ 20 B | ||
|
ICON Public Limited Company
ICLR
|
8.31 | $ 110.37 | 3.33 % | $ 9.1 B | ||
|
Laboratory Corporation of America Holdings
LH
|
10.17 | $ 264.18 | 1.25 % | $ 22 B | ||
|
Celcuity
CELC
|
-176.06 | $ 120.4 | 2.78 % | $ 5.63 B | ||
|
Myriad Genetics
MYGN
|
-99.43 | $ 4.59 | 5.52 % | $ 425 M | ||
|
NeoGenomics
NEO
|
-12.91 | $ 8.0 | 4.03 % | $ 1.02 B | ||
|
Neogen Corporation
NEOG
|
-52.72 | $ 9.14 | -2.97 % | $ 1.98 B | ||
|
Lantheus Holdings
LNTH
|
21.43 | $ 81.67 | 1.34 % | $ 5.51 B | ||
|
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | ||
|
Natera
NTRA
|
-77.62 | $ 201.9 | 4.6 % | $ 19.9 B | ||
|
Invitae Corporation
NVTA
|
-98.02 | - | - | $ 21.2 M | ||
|
Quest Diagnostics Incorporated
DGX
|
13.84 | $ 192.91 | 0.73 % | $ 21.4 B | ||
|
ENDRA Life Sciences
NDRA
|
-310.93 | $ 5.19 | 5.06 % | $ 4.08 M | ||
|
National Research Corporation
NRC
|
82.92 | $ 16.82 | 2.03 % | $ 376 M | ||
|
Organovo Holdings
ONVO
|
-23.71 | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
162.49 | - | -16.95 % | $ 1.54 M | ||
|
Pacific Biosciences of California
PACB
|
-10214.54 | $ 1.45 | 8.21 % | $ 435 M | ||
|
Psychemedics Corporation
PMD
|
-62.26 | - | -1.84 % | $ 15.3 M |